Stockreport

Why Axsome Therapeutics (AXSM) Is Up 17.5% After Dual FDA Boosts For AXS-05 And AXS-12 – And What's Next [Yahoo! Finance]

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com
PDF in Alzheimer's disease, while also confirming that its data package for AXS-12 in narcolepsy is sufficient to support a New Drug Application filing. These twin regulat [Read more]